Inventor · disambiguated record
Royal J. Haskell, Iii
Also filed as: HASKELL III ROYAL J · HASKELL ROYAL J
5 granted patents·11 pending applications·26 citations·filing 2000–2025
75Inventor score
Top patents by PatentIndex Score
16 records- 0187US12043612B2Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the sameARVINAS OPERATIONS INC·Filed 2021·Granted Jul 23, 2024·3 cites·12 claims
- 0280US7172769B2Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectPHARMACIA CORP·Filed 2000·Granted Feb 6, 2007·13 cites·17 claims
- 0377US6814319B2Laboratory scale milling processUPJOHN CO·Filed 2001·Granted Nov 9, 2004·10 cites·49 claims
- 0468US2025120968A1Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0567US2023128132A1Methods of treating prostate cancerARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 0665US2025059168A1Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0763US2024409529A1Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the SameARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0860US12162859B2Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptorARVINAS OPERATIONS INC·Filed 2021·Granted Dec 10, 2024·0 cites·6 claims
- 0958US12208095B2Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2020·Granted Jan 28, 2025·0 cites·31 claims
- 1057US2021113557A1Methods of treating prostate cancerARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 1154US2024336566A1Crystalline forms of a compound for the targeted degradation of the androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1252US2022193072A1Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraderARVINAS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1348US2002142045A1Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectFiled 2002·Application pending·0 cites
- 1446US2003064098A1Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectFiled 2001·Application pending·0 cites
- 1545US2025332110A1Pharmaceutical formulations of an androgen receptor-targeting protein degraderARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 1642US2005023386A1Laboratory scale milling processFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Royal J. Haskell, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →